Archive
All news.
Hawthorne Health Named a Finalist for the 2026 SCRS Global Excellence in Patient Centricity Award
Recognition reflects a model that embeds research sites inside independent community pharmacies and supports patients with a nationwide at-home visit network, bringing trials within reach of the communities Hawthorne Health serves.
ReadHawthorne Health Strengthens Executive Team with Key Leadership Appointments
Ricky de Lemos appointed Chief Operating Officer and Marc Leighton joins as Chief Product Officer.
ReadHawthorne Health Delivers Critical Trial Support for Reflow Medical's FDA Approval for Novel Treatment of Peripheral Artery Disease
In-home and community-based operational support for the DEEPER REVEAL trial contributed to FDA clearance of the Spur Peripheral Retrievable Stent System.
ReadSCRS Announces Collaboration with Hawthorne Health as New Global Impact Partner
Hawthorne Health joins the Society for Clinical Research Sites as a Global Impact Partner.
ReadHawthorne Health Strengthens Leadership and Board of Directors
New CEO and board appointees from Labcorp, CVS Health and Northpond Ventures join to fuel company's rapid growth and leadership position within the clinical trials market.
ReadLabcorp and Hawthorne Health Collaborate to Bring Clinical Trials Directly to Patients and Investigators in Local Communities
Collaboration aims to improve patient experience, accessibility and efficiency in decentralized clinical trials.
ReadHawthorne Health Announces Monumental Diversity in Patient Recruitment Data for Valvular Heart Disease Study
The study marks a new standard for inclusive medicine with recruitment for target demographics reaching over 3x the national average.
Read